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Introduction
The diseases that are commonly referred to as ovarian cancer in the vast majority of cases develop from the malignant transformation of a single cell type, the surface epitheUum. Hov^^ever, the biological mechanisms leading to transformation remain unclear. The goal of this project is to elucidate some of the genetic and biological determinants of ovarian cancer, focusing on an in vitro model for ovarian cancer that we have developed (1-4). We have initiated primary human ovarian surface epithelial (HOSE) cell cultures and have successfully derived HOSE cell lines that have undergone immortalization and spontaneous transformation in vitro and can form tumors in vivo. Furthermore, we found that inmiortalization and transformation of HOSE cells can differ in the pathway used for telomere length maintenance, a phenomenon that we have also observed in the clinical disease. Maintenance of telomeric repeats is required for immortalization and is conmionly associated with activity of telomerase [reviewed in (5)]. However, a number of tumors and tumor cell lines have been described that do not have telomerase activity in which the telomere length dependent limitation on cell division is circumvented by a mechanism called Alternative Lengthening of Telomeres (ALT) (6) . We have recently found that 30% of advanced stage ovarian adenocarcinomas lack telomerase activity and thus would be refractory to treatment with telomerase inhibitors. The ALT pathway also represents a salvage pathway that may be activated in tumors in response to short telomeres arising as a consequence of telomerase inhibition. We have found that the majority of our HOSE cell cultures use the ALT pathway for telomere maintenance, thereby providing an in vitro model to characterize the underlying basis of the ALT pathway in ovarian cancer. The mechanism(s) leading to ALT is unknown yet is clearly important in tumorigenesis. Using our HOSE tissue culture model and powerful molecular genetic screening tools we propose to uncover genes of relevance to ALT and malignant transformation of the ovarian surface epithelial cells.
Body
We have made progress on the following tasks proposed during the second year of funding:
Characterization of 50 ovarian tumors for mechanism of telomere maintenance We have completed characterization of an additional 50 ovarian tumors for telomerase activity versus ALT ( Figure 1 and Table 1 ). Of the 50 tumors characterized, 28 contained detectable telomerase activity using 0.5 ug of extract. The remaining tumor extracts did not exhibit telomerase activity. To confirm whether these tumors were in fact telomerase negative, additional TRAP assays using a range of extract (from 0.05 ug to 5 ug) were carried out. In addition, telomerase negative tumors were reassessed following preparation of a second extract. Upon completion of this analysis an additional 9 tumors were determined to contain telomerase activity. Therefore, 36 out of 50 ovarian tumors analyzed (72%) were found to be telomerase positive.
Southern blot analysis was carried out to determine telomere length in 9 of the 14 telomerase negative tumors where sufficient DNA was available. In addition, telomere length was determined for 16 of the telomerase positive tumors. This analysis yielded two tumors with the ultra-long telomeres (>20Kb) that are characteristic of the ALT pathway ( Figure 2 and data not shown). The remaining 7 telomerase negative tumors had telomere lengths similar to those seen in telomerase positive tumors.
Cell lines that utilize the ALT pathway for telomere maintenance contain large multiprotein complexes in which telomeric proteins and DNA co-localize with the PML nuclear body, called ALT-associated PML nuclear bodies (APBs) (7) . To determine if the tumors with telomere lengths within the size range typically seen of telomerase positive tumors were also using the ALT pathway for telomere maintenance, we are analyzing these tumors for the presence of APBs. This analysis required optimization of the ability to detect these structures in paraffin embedded tissue sections. This technical optimization has been carried out and we are able to detect APBs in paraffin embedded sections. Analysis of tumors is currently underway. In this aspect, we have recently improved our ability to profile the RNA expression patterns of these tumors. First, we have derived oUgonucleotides microarray. We have found that oUgonucleotides microarrays give superior quality of hybridization signal relative to cDNA arrays by reducing non-specific binding and thus general background. These arrays contain 29,952 oUgonucleotides that have been spotted onto polylysine coated microscopic glass sUdes. Each oligo in the set is 50 bp in length, correspond to HPSF® (High Purity Salt Free) quality standard and was designed to a coding region of a unique gene. Arrays have been spotted using a GeneMachine Omnigrid arrayer (GeneMachine, San Carlos, CA). From each batch of slides, one undergoes strict quality control for spot morphology and DNA abundance. Secondly, we have refined methods to amplify the RNA from microdissected tumor cells. We have recently evaluated RNA from -10,000 microdissected cells. .
Key Research Accomplishments
• 
Conclusions
The presence of telomerase activity in the majority of tumors and the absence of activity in most human somatic cells has made telomerase an attractive target for cancer therapeutics. Telomerase inhibition can arrest the growth of tumor cells both in vivo and in vitro. Although these approaches deserve close attention, the presence of telomerase-independent mechanisms for telomere maintenance should not be ignored. Tumors using a telomerase independent mechanism, i.e., ALT (Alternative Lengthening of Telomeres), to maintain telomeric arrays would most Ukely be refractory to treatment with telomerase inhibitors. Likewise, the ALT pathway represents a salvage pathway that may be activated in tumors in order to overcome therapeutic effects of telomerase inhibitors. It is our hypothesis that identification of the genes that contribute to telomerase independent telomere maintenance in human cells would allow for the development of strategies to combat growth of a significant percentage of ovarian tumors and/or may suggest strategies for prevention. We have made substantial progress towards identifying gene expression changes relevant to ALT and malignant transformation of the ovarian surface epithelial cells. Functional validation of the role of these candidates in malignant transformation of ovarian surface epithelial cells and/or ALT is ongoing. Those genes that are determined to be important in these processes will represent new targets for diagnosis and therapy.
